Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain)

Introduction: Neonatal Abstinence Syndrome (NAS) is considered a Public Health problem that is defined as a group of symptoms that appear in the newborn due to withdrawal from intrauterine drug exposure. Objective: The aim of this study was to analyze the incidence of NAS in Castilla y León from 200...

Full description

Bibliographic Details
Main Authors: Miriam Moreno-Ramos, Mercedes Sánchez-Barba, Rubén García Sánchez, José Antonio Mirón-Canelo, Veronica González-Nuñez
Format: Article
Language:English
Published: MDPI AG 2021-12-01
Series:Children
Subjects:
Online Access:https://www.mdpi.com/2227-9067/9/1/25
_version_ 1827666211461136384
author Miriam Moreno-Ramos
Mercedes Sánchez-Barba
Rubén García Sánchez
José Antonio Mirón-Canelo
Veronica González-Nuñez
author_facet Miriam Moreno-Ramos
Mercedes Sánchez-Barba
Rubén García Sánchez
José Antonio Mirón-Canelo
Veronica González-Nuñez
author_sort Miriam Moreno-Ramos
collection DOAJ
description Introduction: Neonatal Abstinence Syndrome (NAS) is considered a Public Health problem that is defined as a group of symptoms that appear in the newborn due to withdrawal from intrauterine drug exposure. Objective: The aim of this study was to analyze the incidence of NAS in Castilla y León from 2000 to 2019. Methodology: Data of NAS cases in Castilla y León from 2000 to 2019 were obtained. NAS incidence per 1000 births was calculated and the correlation among data from different provinces and years was analyzed. Results: The cumulative incidence of NAS in Castilla y León per 1000 births between 2000-2019 was 0.91‰, with great interprovincial variability. The provinces of Zamora and Palencia stand out, with high incidence rates of NAS despite their low birth rates. The temporal trend points towards a decrease in incidence from 2000 to 2019. Opioids such as methadone, cannabis, benzodiazepines and poly-drug use are the most prevalent drugs causing NAS, and it has also been observed that methadone is being replaced by cannabis as the major cause of NAS cases at the University Hospital in Salamanca in recent years. Conclusions: The incidence of NAS in Castilla y León decreased in 2004 and remained constant until 2019, but it shows great interprovincial variability. It is necessary to implement a national NAS Registry to obtain comprehensive information regarding its incidence.
first_indexed 2024-03-10T01:43:43Z
format Article
id doaj.art-e18a271273cc4c2791f51d758605b740
institution Directory Open Access Journal
issn 2227-9067
language English
last_indexed 2024-03-10T01:43:43Z
publishDate 2021-12-01
publisher MDPI AG
record_format Article
series Children
spelling doaj.art-e18a271273cc4c2791f51d758605b7402023-11-23T13:20:38ZengMDPI AGChildren2227-90672021-12-01912510.3390/children9010025Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain)Miriam Moreno-Ramos0Mercedes Sánchez-Barba1Rubén García Sánchez2José Antonio Mirón-Canelo3Veronica González-Nuñez4Faculty of Medicine, University of Salamanca, 37008 Salamanca, SpainDepartment of Statistics, Faculty of Medicine, University of Salamanca, 37008 Salamanca, SpainDepartment of Pediatrics, University Hospital of Salamanca, 37008 Salamanca, SpainInstitute of Biomedical and Diagnostic Sciences (IBSAL), 37007 Salamanca, SpainInstitute of Biomedical and Diagnostic Sciences (IBSAL), 37007 Salamanca, SpainIntroduction: Neonatal Abstinence Syndrome (NAS) is considered a Public Health problem that is defined as a group of symptoms that appear in the newborn due to withdrawal from intrauterine drug exposure. Objective: The aim of this study was to analyze the incidence of NAS in Castilla y León from 2000 to 2019. Methodology: Data of NAS cases in Castilla y León from 2000 to 2019 were obtained. NAS incidence per 1000 births was calculated and the correlation among data from different provinces and years was analyzed. Results: The cumulative incidence of NAS in Castilla y León per 1000 births between 2000-2019 was 0.91‰, with great interprovincial variability. The provinces of Zamora and Palencia stand out, with high incidence rates of NAS despite their low birth rates. The temporal trend points towards a decrease in incidence from 2000 to 2019. Opioids such as methadone, cannabis, benzodiazepines and poly-drug use are the most prevalent drugs causing NAS, and it has also been observed that methadone is being replaced by cannabis as the major cause of NAS cases at the University Hospital in Salamanca in recent years. Conclusions: The incidence of NAS in Castilla y León decreased in 2004 and remained constant until 2019, but it shows great interprovincial variability. It is necessary to implement a national NAS Registry to obtain comprehensive information regarding its incidence.https://www.mdpi.com/2227-9067/9/1/25Neonatal Abstinence Syndrome (NAS)substance use disorderopiatesCastilla y Leóncorrelational researchbiplot
spellingShingle Miriam Moreno-Ramos
Mercedes Sánchez-Barba
Rubén García Sánchez
José Antonio Mirón-Canelo
Veronica González-Nuñez
Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain)
Children
Neonatal Abstinence Syndrome (NAS)
substance use disorder
opiates
Castilla y León
correlational research
biplot
title Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain)
title_full Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain)
title_fullStr Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain)
title_full_unstemmed Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain)
title_short Incidence of Neonatal Abstinence Syndrome (NAS) in Castilla y Leon (Spain)
title_sort incidence of neonatal abstinence syndrome nas in castilla y leon spain
topic Neonatal Abstinence Syndrome (NAS)
substance use disorder
opiates
Castilla y León
correlational research
biplot
url https://www.mdpi.com/2227-9067/9/1/25
work_keys_str_mv AT miriammorenoramos incidenceofneonatalabstinencesyndromenasincastillayleonspain
AT mercedessanchezbarba incidenceofneonatalabstinencesyndromenasincastillayleonspain
AT rubengarciasanchez incidenceofneonatalabstinencesyndromenasincastillayleonspain
AT joseantoniomironcanelo incidenceofneonatalabstinencesyndromenasincastillayleonspain
AT veronicagonzaleznunez incidenceofneonatalabstinencesyndromenasincastillayleonspain